Skip to main content
Log in

Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin

Respiratorische Insuffizienz als Folge einer Streptokokkenseptikämie bei Patienten unter Cytosin Arabinosid-Therapie und ihre Prävention durch Penicillin

  • Review
  • Published:
Infection Aims and scope Submit manuscript

Summary

In order to prevent septicaemia with streptococci, 20 consecutive selectively decontaminated patients on intermediate high-dose Ara-C treatment for malignant haematological disease were given pencillin G. The incidence of infection with streptococci decreased from 0.76 per episode (14 patients, 17 episodes) for controls who did not receive penicillin G to 0.11 per episode in the prophylaxis group (20 patients, 26 episodes). Simultaneously, a decrease in the incidence of respiratory failure was observed, i. e. 0.52 per episode for controls and 0.19 per episode for patients on penicillin G. The results suggest that septicaemia with streptococci triggers the development of noncardiogenic pulmonary oedema in patients with pre-existing damage of the lung due to aggressive cytotoxic treatment. This suggestion is supported by the sequence of events, regarding the occurrence of infection and respiratory failure and the results of measurements of antileukoprotease serum concentrations, a paramenter for pulmonary capillary leakage. Taking into account the data in the literature and the results of the present study, the conclusion is drawn that in patients treated with (intermediate) high dose Ara-C, prevention of streptococcal septicaemia is associated with a decrease in the incidence of respiratory failure.

Zusammenfassung

20 Patienten, die konsekutiv unter selektiver Dekontamination wegen maligner hämatologischer Erkrankungen mit einer mittelgradigen Hoch-Dosis-Ara-C-Therapie standen, erhielten zur Prävention von Streptokokkenseptikämien Penicillin G. Verglichen mit einer Kontrollgruppe (14 Patienten, 17 Zyklen), in der ohne Penicillinprophylaxe 0,76 Streptokokkeninfektionen pro Zyklus auftraten, war die Inzidenz dieser Komplikation unter Penicillin G-Prophylaxe bei 20 Patienten in 26 Zyklen mit 0,11 Streptokokkeninfektionen pro Therapiezyklus geringer. Zugleich wurde beobachtet, daß im Vergleich zur Kontrollgruppe mit 0,19 gegenüber 0,52 Fällen pro Zyklus bei Patienten unter Penicillin-G-Prophylaxe weniger häufig eine respiratorische Insuffizienz auftrat. Aus den Ergebnissen der Studien läßt sich schließen, daß die Streptokokkenseptikämie einen Trigger für die Entstehung eines nicht kardiogenen Lungenödems bei Patienten mit vorbestehender Lungenschädigung infolge aggressiver Zytostatikatherapie darstellt. Diese Annahme wird unterstützt durch den Ablauf der Ereignisse, das gemeinsame Auftreten von Infektion und respiratorischer Insuffizienz und die Meßwerte für die Antileukoprotease-Konzentrationen im Serum, einen Parameter für erhöhte Durchlässigkeit im Lungenkapillarbett. Aus publizierten Daten und Ergebnissen der vorliegenden Studie wird geschlossen, daß die Prävention der Streptokokkenseptikämie bei Patienten, die eine (mittelgradige) Hoch-Dosis-Therapie mit Ara-C erhalten, auch die Inzidenz der respiratorischen Insuffizienz bei diesen Patienten vermindert.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Guiot, H. F. L., van Furth, R. Selective antimicrobial modulation of the intestinal flora. Editorial. Infection 12 (1983) 1–4.

    Google Scholar 

  2. Guiot, H. F. L., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J. Infect. Dis. 143 (1981) 644–654.

    Google Scholar 

  3. Guiot, H. F. L., van den Broek, P. J., van der Meer J. W. M., van Furth, R. Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebocontrolled study. J. Infect. Dis. 147 (1983) 615–623.

    Google Scholar 

  4. Guiot, H. F. L., Helmig-Schurter, A. V, van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures. Scand. J. Infect. Dis. 18 (1986) 153–160.

    Google Scholar 

  5. Cohen, J., Worsley, A. M., Goldman, J. M., Donnelly, J. P., Catovsky, D., Galton, D. A. G. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet ii (1983) 1452–1454.

    Google Scholar 

  6. Bostrom, B., Weisdorf, D. Mucositis and streptococcal sepsis in bone marrow transplant recipients. Letter to the Editor. Lancet i (1984) 1120–1121.

    Google Scholar 

  7. Pizzo, P. A., Ladisch, S., Simon, R. M. Increasing incidence of gram-positive sepsis in cancer patients. Med. Pediatr. Oncol. 5 (1978) 241–244.

    Google Scholar 

  8. Pizzo, P. A., Ladisch, S., Witebsky, F. G. Alpha haemolytic streptococci: Clinical significance in the cancer patient. Med. Pediatr. Oncol. 4 (1978) 367–370.

    Google Scholar 

  9. Bow, E. J., Rayner, E., Pitsanuk, J., Loui, T. J.: A comparative trial of norfloxacin (N) and trimethoprim/sulfamethoxazole (T/S) for infection prophylaxis (P) in patients (PTS) with acute leukaemia (AL). Proc. 4th International Symposium on Infections in the Immunocompromised Host. Ronneby Brunn, Sweden, June 15–19, 1986, p. 93.

  10. Rozenberg-Arska, M., Dekker, A. W., Verdonck, L. F., Verhoef, J.: Prevention of gram-positive bacteremias by a short course of roxithromycin (RU) in granulocytopenic patients receiving ciprofloxacin (CF) prophylactically. Proc. 5th International Symposium on Infections in the Immonocompromised Host. Leeuwenhorst Congress Center, Noordwijkerhout, the Netherlands, June 5–8, 1988, abstract no. 52a.

  11. Van de Leur, J. J. P. M., Clasener, H. A. L., Vollaard, E. J., van Turnhout, J. M.: Selective decontamination of the digestive tract (SDD) for infection prevention in neutropenia. Proc. 5th International Symposium on Infection in the Immunocompromised Host. Leeuwenhorst Congress Center, Noordwijkerhout, the Netherlands, June 5–8, (1988), abstract no. 26.

  12. Donnelly, J. P., Novakova, I. R. O., van Loon, T. M., de Witte, T., de Pauw, B. E: Risk factors involved in the development of bacteraemia due to “viridans” streptococci in neutropenic patients. Proc. 5th International Symposium on Infections in the Immunocompromised Host. Leeuwenhorst Congress Center, Noordwijkerhout, the Netherlands, June 5–8, 1988, abstract no. 12.

  13. Willemze, R., Peters, W. G., van Hennik, M. B., Fibbe, W. E., Kootte, A. M. M., van Berkel, M., Lie, R., Rodenburg C. J., Veltkamp, J. Intermediate and high-dose Ara-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin's lymphoma. Scand. J. Haematol. 34 (1985) 83–87.

    Google Scholar 

  14. Peters, W. G., Willemze, R., Colly, L. P., Guiot, H. F. L. Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma. Neth. J. Med. 30 (1987) 64–74.

    Google Scholar 

  15. Tjon A Tham, R. T. O., Peters, W. G., de Bruine, F. T., Willemze, R. Pulmonary complications of cytosine-arabinoside therapy: radiographic findings. Am. J. Roentgenol. 149 (1987) 23–27.

    Google Scholar 

  16. Pepe, P. E., Potkin, R. T., Reus, D. H., Dudson, L. D., Carrico, C. J. Clinical predictors of the adult respiratory distress syndrome. Am. J. Surg. 144 (1982) 124–130.

    Google Scholar 

  17. Fleck, A., Raines, G., Hawker, F., Trotters, J., Wallace, P. I., Ledingham, I. M. A., Calman, K. C. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet i (1985) 781–784.

    Google Scholar 

  18. Haupt, H. M., Hutchins, G. M., Moore, G. W. Ara-C lung: noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia. Am. J. Med. 70 (1981) 256–261.

    Google Scholar 

  19. Groot-Loonen, J. J., van der Noordaa, J., de Kraker, J., Voute, P. A., van Leeuwen, E. F., Terpstra, W. J., Ansink-Schipper, M. C. Alpha-hemolytic streptococcal septicemia with severe complications during neutropenia in childhood cancer. Ped. Hemat. Onc. 4 (1987) 323–328.

    Google Scholar 

  20. Fryksmark, U., Prellner, T., Tegner, H., Ohlsson, K. Studies on the role of antileukoprotease in respiratory tract disease. Eur. J. Respir Dis. 65 (1984) 201–209.

    Google Scholar 

  21. Guiot, H. F. L., Biemond, J., Klasen, E., Gratama, J. W., Kramps, J. A., Zwaan, F. E. Protein loss during acute graft-versus-host disease: diagnostic and clinical significance. Eur. J. Haematol 38 (1987) 187–196.

    Google Scholar 

  22. De Water, R., Willems, L. N. A., van Muijen, G. N. P., Franken, C., Fransen, J. A. M., Dijkman, J. H., Kramps, J. A. Ultrastructural localization of bronchial antileukoprotease in central and peripheral human airways by a gold-labeling technique using monoclonal antibodies. Am. Rev. Respir. Dis. 133 (1986) 882–890.

    Google Scholar 

  23. Willems, L. N. A., Otto-Verberne, C. J. M., Kramps, J. A., ten Have-Opbroek, A. A. W., Dijkman, J. H. Detection of antileukoprotease in connective tissue of the lung, Histochem. 86 (1986) 165–168.

    Google Scholar 

  24. Dijkman, J. H., Kramps, J. A., Franken, C. Antileukoprotease in sputum during bronchial infections. Chest 89 (1986) 731–736.

    Google Scholar 

  25. Steiner, M., Villablanca, J., Kersey, J., Ramsay, N., Ferrieri, P., Haake, R., Weisdorf, D.: Alpha-streptococcal shock in bone marrow transplantation patients. Blood 72 (1988) (Suppl. 1) 409a (abstract).

  26. Andersson, B. S., Cogan, B. M., Keating, M. J., Estey, E. H., McCredie, K. B., Freireich, E. J. Subacute pulmonary failure complicating therapy with high-dose Ara-C in acute leukemia. Cancer 56 (1985) 2181–2184.

    Google Scholar 

  27. Henslee, J., Bostrom, B., Weisdorf, D., Ramsay, N., McGlave, Ph., Kersey, J. Streptococcal sepsis in bone marrow transplant patients. Lancet i (1984) 393.

    Google Scholar 

  28. Dreyfus, F., Dhainaut, J. F., Varet, B., Brunet, F., Lanore, J. J., Belanger, C., Huyghebaert, M. F., Monsallier, J. F.: Alveolar hemorrhages in neutropenic patients. Proc. 4th International Symposium on Therapy of Acute Leukemias. Rome, February 7–12, 1987, abstract no. 53.

  29. Jehn, U., Goeldel, N., Rienmueller, R., Wilmanns, W. Noncardiogenic pulmonary edema complicating intermediate and high-dose Ara-C treatment for relapsed acute leukemia. Med. Oncol. Tumor Pharmacother. 5 (1988) 41–47.

    Google Scholar 

  30. Kahn, S. B., Begg, C. B., Mazza, J. J, Bennett, J. M., Bonner, H., Glick, J. H. Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly. J. Clin. Oncol. 2 (1984) 865–870.

    Google Scholar 

  31. Herzig, R. H., Lazarus, H. M., Wolff, S. N., Phillips, G. L., Herzig, G. P. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlympoblastic leukemia. J. Clin. Oncol. 3 (1985) 992–997.

    Google Scholar 

  32. Wells, R. J., Feusner, J., Devney, R., Woods, W. G., Provisor, A. J., Cairo, M. S., Odom, L. F., Nachman, J., Jones, G. R., Ettinger, L. J., Capizzi, R. L. Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia. J. Clin. Oncol. 3 (1985) 998–1104.

    Google Scholar 

  33. van der Meer, J. W. M., Guiot, H. F. L., van den Broek, P. J., van Furth R. Infections in bone marrow transplant recipients. Semin. Hematol. 21 (1984) 123–140.

    Google Scholar 

  34. de Marie, S., van den Broek, P. J., van Furth, R.: Restrictive antibiotic approach to the selectively decontaminated neutropenic patient with fever. Abstract, VIth International Symposium on Infections in the Immunocompromised Host. Noordwijkerhout, The Netherlands, June 1988.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guiot, H.F.L., van der Meer, J.W.M., van Furth, R. et al. Respiratory failure elicited by streptococcal septicaemia in patients treated with cytosine arabinoside, and its prevention by penicillin. Infection 18, 131–137 (1990). https://doi.org/10.1007/BF01642100

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01642100

Keywords

Navigation